article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. — Professor Karol Sikora (@ProfKarolSikora) April 22, 2020. — Tatiana Prowell, MD (@tmprowell) May 11, 2020. — Aditya Bardia, MD (@ABhealer108) March 14, 2020.

Hospitals 124
article thumbnail

2022 UK life sciences recruitment report revealed

European Pharmaceutical Review

The report by Cpl Life Sciences and market data analysts Vacancysoft found that within the laboratory function: From 2020-22, there were over 2,700 job postings In 2022, there were over 1,000 new scientific vacancies. The most prominent being Clinical Projects and Clinical Management, down 30.9 percent). percent and 30.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Emerging therapeutic approaches in paroxysmal nocturnal haemoglobinuria

Hospital Pharmacy Europe

7,8 Additionally, the psychological impact of PNH, including increased anxiety and depression, complicates clinical management and highlights the need for effective, long-term therapeutic strategies. Ther Adv Rare Dis 2020;Oct 22. Ann Hematol 2022;101(2):25163. 8 Griffin M, Kelly R, Pike A. 9 Brodsky RA et al.

article thumbnail

Daily steps AI model able to predict unplanned hospitalisation during chemo-radiation

Hospital Pharmacy Europe

Globally, cancer is a leading cause of death and the World Health Organisation has estimated that in 2020, there were nearly 10 million deaths in 2020. While oncologists are responsible for the management of cancer patients, these individuals may also develop treatment-related side-effects, prompting an emergency department (ED) visit.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

The FDA describes these products under enforcement discretion if they are intended to inform clinical management for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. Published 2 October 2020.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

The FDA describes these products under enforcement discretion if they are intended to inform clinical management for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. Published 19 October 2020.